Conception
Stem cell research platform developing lab-made reproductive cells for people facing fertility barriers
Highlights
- New on EvolcAdded 2026-11-14
About Conception
Conception develops stem cell technology to produce reproductive cells in the laboratory, with a focus on deriving functional eggs from stem cells. Its work combines developmental biology, tissue engineering, computation, organoids and genetic screening to study in-vitro gametogenesis.
The company is based in Berkeley, where its open roles include research and scientific positions in stem cell biology, RNA delivery and organoids.
Product: A research platform for deriving and studying reproductive cells, including functional eggs, from stem cells.
Jobs at Conception
More biotech & pharma companies
Corcept Therapeutics
Develops cortisol-modulating medicines for patients with serious diseasesCountable Labs
Single-molecule PCR instruments, assays and testing services for genomics and life-science researchersRemote-friendlyCSBio
Automated peptide synthesizers for labs, pilot plants and GMP manufacturers, from benchtop to 1000 L scaleNew on EvolcDeciphera Pharmaceuticals
Develops and commercializes medicines for patients with oncology, neurology, and immunology and inflammation conditionsNew on EvolcDeep Origin
AI-powered drug discovery tools and research partnerships for pharmaceutical companies, biotech firms, and scientistsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- FramerHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- AshbyMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.